Kendle International Inc.Cincinnati, OH, United States (NASDAQ (GS): KNDL)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Kendle Company Description

When it comes to research and development, few can hold a candle to Kendle International. A leading contract research organization (CRO) for the biotechnology and pharmaceutical industries, the company provides services that facilitate Phase I through Phase IV clinical trials; those services include patient recruitment, clinical monitoring, statistical analysis, and consulting on regulatory issues. Additionally, Kendle's TrialWare software helps customers manage research and clinical trial data. The company has expertise in a range of therapeutic areas, including oncology, the central nervous system, cardiovascular disease, and inflammation. Kendle has operations around the globe.

View the Comprehensive Company Description for Kendle

The Company Description provides a historical perspective of Kendle's organization from inception to current status.

Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Kendle's evolution in the marketplace.

Start your free trial today